Biorasi Selects IBM Watson Health as Preferred Vendor
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Biorasi, a leading global full-service contract research organization (CRO), has been named on the Inc. 5000 list of the fastest-growing private companies for 2020.
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Site Selection: Building a Bridge with Clinical Sites During COVID-19 Studies
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Disease Management: Finding an Epidemiological Foothold for COVID-19 Clinical Trials
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
Running a COVID-19 Study? Gear Up and Get Your Head in the Game
Biorasi is a full-service global CRO, experienced and engaged in the management of multiple coronavirus clinical trials. For companies ready to start up and initiate on potential opportunities to develop interventions and treatments for COVID-19, we are ready for action.
COVID-19. An Impulse for a Dynamic Operation
The current heath emergency caused by the pandemic has placed health systems around the world under extreme pressure. One of the biggest challenges that the industry faces is overcoming the inexperience of handling such a grave condition, one with few common symptoms.
Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020
Biorasi Kicks-Off Third COVID-19 Clinical Trial for 2020
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
Biorasi has met the First Patient, First Visit milestone for a dermatology trial across multiple sites during the COVID-19 pandemic.
